HB Wealth Management’s Checkpoint Therapeutics CKPT Stock Holding History

HB Wealth Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-180,560	Closed	-$729K	–	1188
2025 Q1	$729K	Buy	180,560 +27,000	+18%	+$90K	0.01%	636
2024 Q4	$513K	Buy	153,560 +75,560	+97%	+$256K	0.01%	613
2024 Q3	$175K	Buy	+78,000	New	+$180K	﹤0.01%	907

HB Wealth Management's CKPT Position: Q2 2025 in Review

HB Wealth Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 180,560 shares — an estimated $729K sold.

HB Wealth Management first reported a position in CKPT in Q3 2024 and held it in 3 quarters. The position peaked at $729K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

HB Wealth Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
HB Wealth Management sold 180,560 Checkpoint Therapeutics shares in Q2 2025, an estimated $729K.
HB Wealth Management first reported a position in Checkpoint Therapeutics in Q3 2024 and held it in 3 quarters.
HB Wealth Management's Checkpoint Therapeutics position peaked at $729K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on HB Wealth Management's 13F filing for Q2 2025, filed 17 Jul 2025.